5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 65.51▼ | 65.14▲ | 64.86▲ | 63.20▲ | 62.39▲ |
MA10 | 65.51▼ | 64.42▲ | 63.80▲ | 62.60▲ | 50.46▲ |
MA20 | 65.25▼ | 63.51▲ | 62.75▲ | 62.33▲ | 35.86▲ |
MA50 | 64.45▲ | 62.42▲ | 61.98▲ | 49.33▲ | 25.51▲ |
MA100 | 63.57▲ | 61.85▲ | 62.13▲ | 35.17▲ | 20.00▲ |
MA200 | 62.69▲ | 62.07▲ | 59.08▲ | 27.87▲ | 19.57▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.054▼ | 0.192▲ | 0.339▲ | -0.718▼ | 3.631▲ |
RSI | 51.534▲ | 66.958▲ | 65.794▲ | 72.507▲ | 80.002▲ |
STOCH | 58.575 | 86.621▲ | 80.899▲ | 75.042 | 90.956▲ |
WILL %R | -70.866 | -25.281 | -17.274▲ | -10.185▲ | -3.585▲ |
CCI | -31.111 | 103.898▲ | 138.091▲ | 199.668▲ | 89.466 |
Friday, August 15, 2025 10:07 AM
Cidara Therapeutics, Inc.'s CD388 shows promise as a superior flu prophylactic. Click for strong trial results, upcoming catalysts, and more about CDTX stock.
|
Tuesday, August 12, 2025 05:34 AM
Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Good afternoon, and welcome to the Cidara Therapeutics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that ...
|
Friday, August 08, 2025 06:20 AM
Cidara Therapeutics (NASDAQ:CDTX), a biotechnology company focused on the development of innovative therapies for infectious diseases and oncology, released its second-quarter 202 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 63.76 | 66.1999 | 62.145 | 65.215 | 632,452 |
14/08/25 | 62.72 | 65.46 | 60.85 | 63.55 | 808,478 |
13/08/25 | 62.50 | 63.27 | 60.30 | 63.25 | 709,702 |
12/08/25 | 62.80 | 64.26 | 60.60 | 62.00 | 303,564 |
11/08/25 | 62.99 | 63.495 | 60.55 | 62.00 | 344,512 |
08/08/25 | 57.79 | 62.3752 | 56.53 | 62.00 | 424,782 |
07/08/25 | 62.71 | 62.79 | 59.57 | 61.73 | 325,896 |
06/08/25 | 62.46 | 62.725 | 60.59 | 61.99 | 561,044 |
05/08/25 | 62.17 | 62.845 | 59.64 | 61.77 | 326,187 |
04/08/25 | 62.90 | 63.48 | 62.135 | 62.46 | 238,321 |
|
|
||||
|
|
||||
|
|